Med Holdings Group Inc. (OTC PINK:YUKA) Announces Exciting New Developments to Drive Growth
Med Holdings Group (OTC PINK:YUKA) has announced key developments in its MedSmart Wellness Centers subsidiary. The company has partnered with American Cell Technology to introduce stem cell innovations, expecting to boost annual revenue by 80% ($1,000,000). The global stem cell market is projected to reach $25 billion by 2028.
The company also announced reaching a $5 million valuation, up from $1 million two years ago. This growth reflects their strategic focus on innovation and market expansion in the wellness and regenerative medicine industry.
Med Holdings Group (OTC PINK:YUKA) ha annunciato sviluppi significativi nella sua controllata MedSmart Wellness Centers. L'azienda ha stretto una partnership con American Cell Technology per introdurre innovazioni nelle cellule staminali, prevedendo un aumento del fatturato annuale dell'80% ($1.000.000). Si prevede che il mercato globale delle cellule staminali raggiunga $25 miliardi entro il 2028.
L'azienda ha inoltre annunciato di aver raggiunto una valutazione di 5 milioni di dollari, rispetto a 1 milione di dollari di due anni fa. Questa crescita riflette il loro focus strategico su innovazione ed espansione di mercato nell'industria del benessere e della medicina rigenerativa.
Med Holdings Group (OTC PINK:YUKA) ha anunciado desarrollos clave en su filial MedSmart Wellness Centers. La empresa se ha asociado con American Cell Technology para introducir innovaciones en células madre, esperando aumentar los ingresos anuales en un 80% ($1,000,000). Se proyecta que el mercado global de células madre alcanzará $25 mil millones para 2028.
La compañía también anunció haber alcanzado una valoración de 5 millones de dólares, subiendo desde 1 millón de dólares hace dos años. Este crecimiento refleja su enfoque estratégico en la innovación y la expansión del mercado en la industria del bienestar y la medicina regenerativa.
메드 홀딩스 그룹 (OTC PINK:YUKA)은 자회사인 MedSmart Wellness Centers에서 주요 발전을 발표했습니다. 이 회사는 American Cell Technology와 파트너십을 맺고 줄기세포 혁신을 도입하여 연간 수익을 80% ($1,000,000) 증가시킬 것으로 예상하고 있습니다. 글로벌 줄기세포 시장은 2028년까지 250억 달러에 이를 것으로 예상됩니다.
회사는 또한 500만 달러의 가치 평가에 도달했다고 발표했습니다. 이는 2년 전 100만 달러에서 증가한 것입니다. 이러한 성장은 웰빙 및 재생 의학 산업에서 혁신과 시장 확장에 대한 전략적 초점을 반영합니다.
Med Holdings Group (OTC PINK:YUKA) a annoncé des développements clés au sein de sa filiale MedSmart Wellness Centers. L'entreprise a noué un partenariat avec American Cell Technology pour introduire des innovations en matière de cellules souches, avec l'espoir d'augmenter ses revenus annuels de 80% ($1.000.000). Le marché mondial des cellules souches devrait atteindre 25 milliards de dollars d'ici 2028.
La société a également annoncé avoir atteint une évaluation de 5 millions de dollars, contre 1 million de dollars il y a deux ans. Cette croissance reflète leur focus stratégique sur l'innovation et l'expansion du marché dans l'industrie du bien-être et de la médecine régénérative.
Med Holdings Group (OTC PINK:YUKA) hat bedeutende Entwicklungen in seiner Tochtergesellschaft MedSmart Wellness Centers bekannt gegeben. Das Unternehmen hat sich mit American Cell Technology zusammengeschlossen, um Innovationen im Bereich der Stammzellen einzuführen. Es wird erwartet, dass der jährliche Umsatz um 80% ($1.000.000) steigen wird. Der globale Markt für Stammzellen wird voraussichtlich bis 2028 25 Milliarden Dollar erreichen.
Das Unternehmen gab außerdem bekannt, dass es eine Bewertung von 5 Millionen Dollar erreicht hat, gegenüber 1 Million Dollar vor zwei Jahren. Dieses Wachstum spiegelt ihren strategischen Fokus auf Innovation und Markterweiterung in der Wellness- und regenerativen Medizinbranche wider.
- Expected 80% increase in annual revenue (+$1,000,000) from stem cell technology integration
- Company valuation increased from $1M to $5M in two years
- Strategic partnership with American Cell Technology for stem cell innovations
- None.
AVENTURA, FLORIDA / ACCESSWIRE / December 17, 2024 / Med Holdings Group Inc. (OTC PINK:YUKA), a leader in health and wellness solutions, is thrilled to announce significant advancements within its MedSmart Wellness Centers subsidiary. These developments position the company for unprecedented growth and further solidify its role as a pioneer in longevity medicine.
Introduction of Stem Cell Technology
MedSmart Wellness Centers is proud to partner with American Cell Technology to introduce cutting-edge stem cell innovations to its clients. As the global stem cell market continues to experience rapid growth-projected to reach over
Stem cell therapies are revolutionizing healthcare by offering solutions for regenerative medicine, anti-aging, and wellness. With this integration, MedSmart is not only enhancing its offerings but also leveraging a significant growth opportunity in one of the fastest-evolving sectors of medical innovation.
The introduction of advanced stem cell technology is expected to boost annual revenue by
By aligning with cutting-edge advancements in stem cell therapies, MedSmart Wellness Centers reaffirm their mission to deliver state-of-the-art solutions that redefine health and wellness for clients.
Med Holdings Group Inc. is also excited to announce a
"Our journey has been one of continuous progress and commitment to transforming the health and wellness industry," said Jessica Miller, CEO of Med Holdings Group Inc. "The integration of stem cell technology and our
About Med Holdings Group Inc.
Med Holdings Group Inc. (OTC PINK:YUKA) is a forward-thinking health and wellness company specializing in longevity medicine. Through its subsidiary, MedSmart Wellness Centers, the company offers innovative solutions designed to enhance the health and quality of life for its clients. With plans for further expansion across Florida, Med Holdings Group is setting a new standard in the medical wellness sector.
About MedSmart Wellness Centers
MedSmart Wellness Centers provide a wide range of advanced health and wellness services, including anti-aging therapies, non-invasive treatments, and now, cutting-edge stem cell technology. Each procedure is delivered by licensed medical professionals dedicated to achieving exceptional outcomes.
For More Information, Please Visit
• Instagram: @Medsmartcenters
• Email: info@medholdingsgroup.com | info@medsmartcenters.com
Contact
Investor Relations
Med Holdings Group Inc.
Phone: 786-438-3100
Email: info@medholdingsgroup.com
Website: www.medholdingsgroup.com
Jessica Miller
CEO
Med Holdings Group Inc.
Phone: 786-438-3100
Email: info@medholdingsgroup.com
Websites: www.medholdingsgroup.com, www.medsmartcenters.com
Safe Harbor Statement
This release includes "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934. Certain statements set forth in this press release constitute "forward-looking statements." Forward-looking statements include, without limitation, any statement that may predict, forecast, indicate, or imply future results, performance, or achievements and may contain the words "estimate," "project," "intend," "forecast," "anticipate," "plan," "planning," "expect," "believe," "will likely," "should," "could," "would," "may," or words or expressions of similar meaning. Such statements are not guarantees of future performance and are subject to risks and uncertainties that could cause the company's actual results and financial position to differ materially from those included within the forward-looking statements.
SOURCE: Med Holdings Group Inc.
View the original press release on accesswire.com
FAQ
How much additional revenue does YUKA expect from its stem cell technology integration?
What is the current valuation of YUKA stock as of December 2024?
Who is YUKA's new partnership with for stem cell technology?
What is the projected size of the global stem cell market that YUKA is targeting?
